A prescription trend analysis of methylphenidate: relation to study reports on efficacy

Maruschka Sluiter, Ymkje Anna de Vries, Lotte Koning, Eelko Hak, Jens Bos, Catharina Schuiling-Veninga, Laura Batstra, Jeannette Doornenbal, Peter de Jonge

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Use of methylphenidate in children has increased substantially, despite conflicting evidence regarding efficacy. In this study, prescription data were analyzed in relation to the publication of new evidence regarding efficacy. Incidence rates and prescribed doses of methylphenidate increased, with a decline during the last few years. Duration of use is still increasing. In half of the cases, starting dosages are higher than recommended in guidelines. There was little evidence that publication of new evidence directly influenced the use of methylphenidate. Recent and critical study findings should receive more attention to contribute to the development and use of treatment guidelines for ADHD and evidence-based methylphenidate use.
Original languageEnglish
Pages (from-to)291-299
JournalAdministration and Policy in Mental Health and Mental Health Services Research
Volume47
Issue number2
DOIs
Publication statusPublished - 16 Oct 2019

Keywords

  • adhd
  • adolescents
  • methylphenidate
  • prescription trends
  • mta

Fingerprint Dive into the research topics of 'A prescription trend analysis of methylphenidate: relation to study reports on efficacy'. Together they form a unique fingerprint.

Cite this